
Network News

Prestigious funding by the European Research Council for innovative biomedical project Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project in collaboration with teams in Ireland and the United Kingdom. The European Research Council (ERC) is granting this highly endowed funding to advance soft X-ray microscopy. This […]
read more
IHI to pilot novel, applicant-driven approach to next call for proposals
While previous IHI calls defined the challenges applicants should address, call 9 will invite applicants to identify untapped opportunities in the IHI Strategic Research and Innovation Agenda. Key dates and links 10 October: Online info session on the call and the brokerage platform and event – register here Mid October: Publication of the draft call text on our Future […]
read more
TSG Hoffenheim and Heidelberg University Hospital cooperate
TSG Hoffenheim and Heidelberg University Hospital (UKHD) are entering into a partnership to focus more on the topic of mental health. The aim of the cooperation is to bring the Clinic for Child and Adolescent Psychiatry, the Clinic for General Psychiatry and the Sports Psychology Department of TSG closer together. More Information in German below. […]
read more
Psychotherapy via video in the GP practice helps with depression and anxiety
A new digital therapy concept provides people suffering from mental disorders with low-threshold and effective access to specialized psychosocial care. This can usefully complement existing services – as demonstrated by the PROVIDE-C study conducted by the Medical Faculty of Heidelberg University. The study was funded by the Federal Ministry of Education and Research (BMBF). Its […]
read more
Novel NKG2D-targeting bispecific antibodies improve B celllymphoma killing
Combination approach could potentiate the success of immunotherapy MEDICAL NEED: Owing to advances in cancer research, mortality rates have decreased in recent years.1However, there are many patients who do not benefit from the plethora of available therapies becausetumors develop diverse immune escape mechanisms. Therefore, further development, investigation andimprovement of current and new therapies is imperative. […]
read more
Prize of the Teufel Foundation for Nicole Anderle
Yesterday (October 16, 2024), NMI employee Dr. Nicole Anderle was awarded the Reinhold-und-Maria Teufel Foundation Prize for her doctorate on precision oncology. The prize is endowed with 5,000 euros and was presented to the scientist at the foundation’s headquarters in Tuttlingen. The challenges in cancer therapy are immense, especially the resistance to therapy in patients […]
read more
Federal Government appoints Professor Eva Winkler to the German Ethics Council
The German Ethics Council is an expert body that advises parliament and government on social and, above all, medical and bioethical issues. Eva Winkler, Heisenberg Professor for Translational Medical Ethics at the Heidelberg Faculty of Medicine of Heidelberg University, has now been appointed to the Council. As Managing Director at the National Centre for Tumour […]
read more
U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson’s Disease
NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). “For too long, the Parkinson’s community has had […]
read more
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults.1 BOTOX® Cosmetic is the first and only product with four aesthetic indication areas: forehead lines, frown lines, […]
read more